Paper995142
Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination.
Cohen SR and 2 others. N Engl J Med, 1976. Cited by 240 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination. Papers, record 995142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/995142
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cerebrospinal Fluid Proteins | Major topic |
| Demyelinating Diseases | Major topic |
| Multiple Sclerosis | Major topic |
| Myelin Proteins | Major topic |
| Humans | |
| Leukodystrophy, Metachromatic | |
| Myelitis, Transverse | |
| Radioimmunoassay |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 240 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,240,375 | Trajectory of changes in myelin basic protein levels in cerebrospinal fluid during ageing and its association with biomarkers of Alzheimer's disease. | Transl Psychiatry | 2025 | https://conductscience.org/library/papers/40240375 | PubMed |
| 38,389,906 | Modulation of Inflammatory Response by Electromagnetic Field Stimulation in Traumatic Brain Injury in Yucatan Swine. | J Surg Res (Houst) | 2024 | https://conductscience.org/library/papers/38389906 | PubMed |
| 36,510,037 | Central Nervous System Prophylaxis and Treatment in Acute Leukemias. | Curr Treat Options Oncol | 2022 | https://conductscience.org/library/papers/36510037 | PubMed |
| 36,232,832 | The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36232832 | PubMed |
| 35,682,558 | Current and Future Biomarkers in Multiple Sclerosis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682558 | PubMed |
| 34,719,771 | Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment. | Metab Brain Dis | 2022 | https://conductscience.org/library/papers/34719771 | PubMed |
| 34,638,664 | Potential Biomarkers Associated with Multiple Sclerosis Pathology. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34638664 | PubMed |
| 31,906,559 | Deep Brain Stimulation of the Pedunculopontine Tegmental Nucleus Renders Neuroprotection through the Suppression of Hippocampal Apoptosis: An Experimental Animal Study. | Brain Sci | 2020 | https://conductscience.org/library/papers/31906559 | PubMed |
| 30,214,633 | Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis. | Theranostics | 2018 | https://conductscience.org/library/papers/30214633 | PubMed |
| 29,500,303 | Biomarkers in Multiple Sclerosis. | Cold Spring Harb Perspect Med | 2019 | https://conductscience.org/library/papers/29500303 | PubMed |
| 28,549,769 | Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage. | Pathophysiology | 2017 | https://conductscience.org/library/papers/28549769 | PubMed |
| 27,874,212 | Dorsal column myelopathy after intrathecal chemotherapy for leukemia. | Am J Hematol | 2017 | https://conductscience.org/library/papers/27874212 | PubMed |
| 27,058,221 | Multiple sclerosis: genetics, biomarkers, treatments. | Curr Opin Neurol | 2016 | https://conductscience.org/library/papers/27058221 | PubMed |
| 10,502,543 | Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms. | Environ Health Perspect | 1999 | https://conductscience.org/library/papers/10502543 | PubMed |
| 9,358,770 | Mononuclear phagocyte hydrolytic enzyme activity associated with cerebral HIV-1 infection. | Am J Pathol | 1997 | https://conductscience.org/library/papers/9358770 | PubMed |
| 9,343,121 | Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis. | J Neurol Neurosurg Psychiatry | 1997 | https://conductscience.org/library/papers/9343121 | PubMed |
| 7,044,631 | Differences in interaction between immune complexes and complement receptors in serum and cerebrospinal fluid. | Clin Exp Immunol | 1982 | https://conductscience.org/library/papers/7044631 | PubMed |
| 6,194,137 | Myelin basic protein and multiple sclerosis. | Ital J Neurol Sci | 1983 | https://conductscience.org/library/papers/6194137 | PubMed |
| 6,178,397 | The renal degradation of myelin basic protein peptide 43-88 by two enzymes in different subcellular fractions. | Biochem J | 1982 | https://conductscience.org/library/papers/6178397 | PubMed |
| 6,157,784 | Increase in myelin basic protein in CSF after brain surgery. | J Neurol | 1980 | https://conductscience.org/library/papers/6157784 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MBP | 4,155 | PubTator's text mining | https://conductscience.org/library/genes/4155 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/995142
GET https://conductscience.org/api/papers/v1/995142/cited_by?page=2